Filing Details

Accession Number:
0001209191-16-149990
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-14 20:49:04
Reporting Period:
2016-11-10
Filing Date:
2016-11-14
Accepted Time:
2016-11-14 20:49:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401708 Nanostring Technologies Inc NSTG Biological Products, (No Disgnostic Substances) (2836) 200094687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575831 Barney Saunders 530 Fairview Avenue N.
Seattle WA 98109
Svp, Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-10 600 $1.92 6,371 No 4 M Direct
Common Stock Disposition 2016-11-10 3,659 $22.46 2,712 No 4 S Direct
Common Stock Disposition 2016-11-10 1,042 $22.74 1,670 No 4 S Direct
Common Stock Acquisiton 2016-11-11 2,907 $1.92 4,577 No 4 M Direct
Common Stock Acquisiton 2016-11-11 4,375 $6.72 8,952 No 4 M Direct
Common Stock Disposition 2016-11-11 7,282 $22.45 1,670 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-11-10 600 $0.00 600 $1.92
Common Stock Stock Option (right to buy) Disposition 2016-11-11 2,907 $0.00 2,907 $1.92
Common Stock Stock Option (right to buy) Disposition 2016-11-11 4,375 $0.00 4,375 $6.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,907 2022-02-28 No 4 M Direct
0 2022-02-28 No 4 M Direct
625 2023-01-09 No 4 M Direct
Footnotes
  1. The sales reported by Mr. Saunders were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2016.
  2. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $21.70 to $22.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.71 to $22.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $22.13 to $22.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. 15% of the shares subject to the Option vested on March 1, 2012 (the "Vesting Commencement Date"), and thereafter 1/48th of the remaining shares subject to the Option vest on the monthly anniversary of the Vesting Commencement Date.
  6. This option is subject to an early exercise provision and is immediately exercisable. 1/48th of the shares subject to such Option vest on each monthly anniversary of January 10, 2013.